Invesco Biotechnology & Genome ETF
PBE
#2004
ETF Rang
€0.22 Mrd.
Marktkapitalisierung
🇺🇸 US
Markt
70,35 €
Aktienkurs
-1.66%
Veränderung (1 Tag)
7.03%
Veränderung (1 Jahr)
Kategorien

Invesco Biotechnology & Genome ETF - Bestände

ETF-Bestände zum Stand 21. Januar 2026

Anzahl der Bestände: 32

Vollständige Bestandsliste

Gewichtung %NameTickerGehaltene Aktien
5.86%Illumina IncILMN103203
4.99%Gilead Sciences IncGILD103770
4.98%Amgen IncAMGN38885
4.77%Incyte CorpINCY122358
4.77%United Therapeutics CorpUTHR27241
4.77%Regeneron Pharmaceuticals IncREGN17072
4.73%Biogen IncBIIB73517
4.08%Alnylam Pharmaceuticals IncALNY29936
3.83%Amicus Therapeutics IncFOLD716939
3.62%Dynavax Technologies CorpDVAX619803
3.12%QIAGEN NVQGEN150201.3786
2.97%Bio-Techne CorpTECH111680
2.96%ACADIA Pharmaceuticals IncACAD296675
2.94%MannKind CorpMNKD1382171
2.80%Exelixis IncEXEL167824
2.73%Collegium Pharmaceutical IncCOLL155580
2.71%Catalyst Pharmaceuticals IncCPRX301597
2.70%BioMarin Pharmaceutical IncBMRN127758
2.69%Repligen CorpRGEN42392
2.67%Ionis Pharmaceuticals IncIONS90302
2.64%Royalty Pharma PLCRPRX178379
2.60%TG Therapeutics IncTGTX221373
2.60%BioCryst Pharmaceuticals IncBCRX1038146
2.56%Vericel CorpVCEL182370
2.56%Halozyme Therapeutics IncHALO95817
2.53%Neurocrine Biosciences IncNBIX50198
2.53%Protagonist Therapeutics IncPTGX80859
2.50%PTC Therapeutics IncPTCT88821
2.45%Veracyte IncVCYT151832
2.23%Madrigal Pharmaceuticals IncMDGL12061
0.06%Invesco Government & Agency PortfolioAGPXX172681.43
0.02%CASH & EQUIVALENTSUSD47243.11